{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T07:20:53Z","timestamp":1773732053461,"version":"3.50.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T00:00:00Z","timestamp":1225324800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00115-008-2575-2","type":"journal-article","created":{"date-parts":[[2008,10,29]],"date-time":"2008-10-29T00:07:09Z","timestamp":1225238829000},"page":"1263-1272","source":"Crossref","is-referenced-by-count":21,"title":["Restless-legs-Syndrom, periodische Gliedma\u00dfenbewegungen im Schlaf und Psychopharmakologie","Restless legs syndrome, periodic limb movements, and psychopharmacology"],"prefix":"10.1007","volume":"79","author":[{"given":"S.","family":"Cohrs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rodenbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hornyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,30]]},"reference":[{"key":"2575_CR1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0149-2918(04)90136-1","volume":"26","author":"Abetz","year":"2004","unstructured":"Abetz L, Allen R, Follet A et al. (2004) Evaluating the quality of life of patients with restless legs syndrome. Clin Ther 26: 925\u2013935","journal-title":"Clin Ther"},{"key":"2575_CR2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00002826-199704000-00006","volume":"20","author":"Adler","year":"1997","unstructured":"Adler CH (1997) Treatment of restless legs syndrome with gabapentin. Clin Neuropharmacol 20: 148\u2013151","journal-title":"Clin Neuropharmacol"},{"key":"2575_CR3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4088\/JCP.v63n1214a","volume":"63","author":"Agargun","year":"2002","unstructured":"Agargun MY, Kara H, Ozbek H (2002) Restless legs syndrome induced by mirtazapine. J Clin Psychiatry 63: 1179","journal-title":"J Clin Psychiatry"},{"key":"2575_CR4","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4088\/JCP.v68n0810","volume":"68","author":"Aiken","year":"2007","unstructured":"Aiken CB (2007) Pramipexole in psychiatry: a systematic review of the literature. J Clin Psychiatry 68: 1230\u20131236","journal-title":"J Clin Psychiatry"},{"key":"2575_CR5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","volume":"113","author":"Alex","year":"2007","unstructured":"Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113: 296\u2013320","journal-title":"Pharmacol Ther"},{"key":"2575_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","volume":"4","author":"Allen","year":"2003","unstructured":"Allen RP, Picchietti D, Hening WA (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4: 101\u2013119","journal-title":"Sleep Med"},{"key":"2575_CR7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1440-1819.2002.00955.x","volume":"56","author":"Bahk","year":"2002","unstructured":"Bahk WM, Pae CU, Chae JH (2002) Mirtazapine may have the propensity for developing a restless legs syndrome? A case report. Psychiatry Clin Neurosci 56: 209\u2013210","journal-title":"Psychiatry Clin Neurosci"},{"key":"2575_CR8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-510X(96)00180-3","volume":"142","author":"Bakshi","year":"1996","unstructured":"Bakshi R (1996) Fluoxetine and restless legs syndrome. J Neurol Sci 142: 151\u2013152","journal-title":"J Neurol Sci"},{"key":"2575_CR9","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archpsyc.1985.01790320042006","volume":"42","author":"Barnes","year":"1985","unstructured":"Barnes TR, Braude WM (1985) Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 42: 874\u2013878","journal-title":"Arch Gen Psychiatry"},{"key":"2575_CR10","first-page":"1200","volume":"23","author":"Berger","year":"2007","unstructured":"Berger K, Kurth T (2007) RLS epidemiology-Frequencies, risk factors and methods in population studies. Mov Disord 23: 1200\u20131202","journal-title":"Mov Disord"},{"key":"2575_CR11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000065514","volume":"48","author":"Bezerra","year":"2002","unstructured":"Bezerra ML, Martinez JV (2002) Zolpidem in restless legs syndrome. Eur Neurol 48: 180\u2013181","journal-title":"Eur Neurol"},{"key":"2575_CR12","first-page":"655","volume":"55","author":"Bonin","year":"2000","unstructured":"Bonin B, Vandel P, Kantelip JP (2000) Mirtazapine and restless leg syndrome: a case report. Therapie 55: 655\u2013656","journal-title":"Therapie"},{"key":"2575_CR13","doi-asserted-by":"crossref","first-page":"M139","DOI":"10.1093\/geronj\/45.4.M139","volume":"45","author":"Bonnet","year":"1990","unstructured":"Bonnet MH, Arand DL (1990) The use of triazolam in older patients with periodic leg movements, fragmented sleep, and daytime sleepiness. J Gerontol 45: M139\u2013144","journal-title":"J Gerontol"},{"key":"2575_CR14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/jnnp.2005.083345","volume":"77","author":"Brandt-Christensen","year":"2006","unstructured":"Brandt-Christensen M, Kvist K, Nilsson FM et al. (2006) Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study. J Neurol Neurosurg Psychiatry 77: 781\u2013783","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2575_CR15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0893-133X(95)00114-S","volume":"14","author":"Buysse","year":"1996","unstructured":"Buysse DJ, Reynolds CF 3rd, Hoch CC et al. (1996) Longitudinal effects of nortriptyline on EEG sleep and the likelihood of recurrence in elderly depressed patients. Neuropsychopharmacology 14: 243\u2013252","journal-title":"Neuropsychopharmacology"},{"key":"2575_CR16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00004850-198710000-00006","volume":"2","author":"Casas","year":"1987","unstructured":"Casas M, Garcia-Ribera C, Alvarez E et al. (1987) Myoclonic movements as a side-effect of treatment with therapeutic doses of clomipramine. Int Clin Psychopharmacol 2: 333\u2013336","journal-title":"Int Clin Psychopharmacol"},{"key":"2575_CR17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.pnpbp.2005.10.001","volume":"30","author":"Chang","year":"2006","unstructured":"Chang CC, Shiah IS, Chang HA, Mao WC (2006) Does domperidone potentiate mirtazapine-associated restless legs syndrome? Prog Neuropsychopharmacol Biol Psychiatry 30: 316\u2013318","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2575_CR18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2165\/00023210-200822110-00004","volume":"22","author":"Cohrs","year":"2008","unstructured":"Cohrs S (2008) Sleep Disturbances in Patients with Schizophrenia: Impact and Effect of Antipsychotics. CNS Drugs 22(11): 939\u2013962","journal-title":"CNS Drugs"},{"key":"2575_CR19","doi-asserted-by":"crossref","unstructured":"Cohrs S, Rodenbeck A, Guan Z et al. (2004) Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology (Berl) 174: 421\u2013429","DOI":"10.1007\/s00213-003-1759-5"},{"key":"2575_CR20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00004714-199110000-00002","volume":"11","author":"Doghramji","year":"1991","unstructured":"Doghramji K, Browman CP, Gaddy JR, Walsh JK (1991) Triazolam diminishes daytime sleepiness and sleep fragmentation in patients with periodic leg movements in sleep. J Clin Psychopharmacol 11: 284\u2013290","journal-title":"J Clin Psychopharmacol"},{"key":"2575_CR21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0893-133X(95)00148-7","volume":"14","author":"Dorsey","year":"1996","unstructured":"Dorsey CM, Lukas SE, Cunningham SL (1996) Fluoxetine-induced sleep disturbance in depressed patients. Neuropsychopharmacology 14: 437\u2013442","journal-title":"Neuropsychopharmacology"},{"key":"2575_CR22","doi-asserted-by":"crossref","unstructured":"Duggal HS, Mendhekar DN (2007) Clozapine-associated restless legs syndrome. J Clin Psychopharmacol. 27: 89\u201390","DOI":"10.1097\/JCP.0b013e31802e7587"},{"key":"2575_CR23","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/00004714-200010000-00013","volume":"20","author":"Ehrenberg","year":"2000","unstructured":"Ehrenberg BL, Eisensehr I, Corbett KE et al. (2000) Valproate for sleep consolidation in periodic limb movement disorder. J Clin Psychopharmacol 20: 574\u2013578","journal-title":"J Clin Psychopharmacol"},{"key":"2575_CR24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00415-004-0367-6","volume":"251","author":"Eisensehr","year":"2004","unstructured":"Eisensehr I, Ehrenberg BL, Rogge Solti S, Noachtar S (2004) Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa\/benserazid. J Neurol 251: 579\u2013583","journal-title":"J Neurol"},{"key":"2575_CR25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/eujp.2000.0187","volume":"4","author":"Freye","year":"2000","unstructured":"Freye E, Levy J (2000) Acute abstinence syndrome following abrupt cessation of long-term use of tramadol (Ultram): a case study. Eur J Pain 4: 307\u2013311","journal-title":"Eur J Pain"},{"key":"2575_CR26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neucli.2004.02.002","volume":"34","author":"Freye","year":"2004","unstructured":"Freye E, Levy JV, Partecke L (2004) Use of gabapentin for attenuation of symptoms following rapid opiate detoxification (ROD) \u2013 correlation with neurophysiological parameters. Neurophysiol Clin 34: 81\u201389","journal-title":"Neurophysiol Clin"},{"key":"2575_CR27","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.59.10.1573","volume":"59","author":"Garcia-Borreguero","year":"2002","unstructured":"Garcia-Borreguero D, Larrosa O, de la Llave Y et al. (2002) Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 59: 1573\u20131579","journal-title":"Neurology"},{"key":"2575_CR28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1183\/09031936.93.01080762","volume":"1","author":"Guilleminault","year":"1988","unstructured":"Guilleminault C, Crowe C, Quera-Salva MA et al. (1988) Periodic leg movement, sleep fragmentation and central sleep apnoea in two cases: reduction with Clonazepam. Eur Respir J 1: 762\u2013765","journal-title":"Eur Respir J"},{"key":"2575_CR29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0404.1976.tb07621.x","volume":"54","author":"Guilleminault","year":"1976","unstructured":"Guilleminault C, Raynal D, Takahashi S et al. (1976) Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride. Acta Neurol Scand 54: 71\u201387","journal-title":"Acta Neurol Scand"},{"key":"2575_CR30","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/WNL.57.9.1717","volume":"57","author":"Happe","year":"2001","unstructured":"Happe S, Klosch G, Saletu B, Zeitlhofer J (2001) Treatment of idiopathic restless legs syndrome (RLS) with gabapentin. Neurology 57: 1717\u20131719","journal-title":"Neurology"},{"key":"2575_CR31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000072882","volume":"48","author":"Happe","year":"2003","unstructured":"Happe S, Sauter C, Klosch G et al. (2003) Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology 48: 82\u201386","journal-title":"Neuropsychobiology"},{"key":"2575_CR32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0033-3182(98)71370-2","volume":"39","author":"Hargrave","year":"1998","unstructured":"Hargrave R, Beckley DJ (1998) Restless leg syndrome exacerbated by sertraline. Psychosomatics 39: 177\u2013178","journal-title":"Psychosomatics"},{"key":"2575_CR33","first-page":"1191","volume":"143","author":"Heiman","year":"1986","unstructured":"Heiman EM, Christie M (1986) Lithium-aggravated nocturnal myoclonus and restless legs syndrome. Am J Psychiatry 143: 1191\u20131192","journal-title":"Am J Psychiatry"},{"key":"2575_CR34","doi-asserted-by":"crossref","unstructured":"Horiguchi J, Inami Y, Sasaki A et al. (1992) Periodic leg movements in sleep with restless legs syndrome: effect of clonazepam treatment, Jpn J Psychiatry Neurol 46: 727\u2013732","DOI":"10.1111\/j.1440-1819.1992.tb00548.x"},{"key":"2575_CR35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1439-054X.2005.00050.x","volume":"9","author":"Hornyak","year":"2006","unstructured":"Hornyak M, Kopasz M, Rodenbeck A et al. (2006) Influence of low-dose doxepin on periodic leg movements in primary insomnia patients. Somnologie 9: 111\u2013115","journal-title":"Somnologie"},{"key":"2575_CR36","doi-asserted-by":"crossref","unstructured":"Jaskiw GE, Popli AP (2004) A meta-analysis of the response to chronic L-dopa in patients with schizophrenia: therapeutic and heuristic implications. Psychopharmacology (Berl) 171: 365\u2013374","DOI":"10.1007\/s00213-003-1672-y"},{"key":"2575_CR37","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.pnpbp.2007.03.011","volume":"31","author":"Kang","year":"2007","unstructured":"Kang SG, Lee HJ, Jung SW et al. (2007) Characteristics and clinical correlates of restless legs syndrome in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31: 1078\u20131083","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2575_CR38","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.wnf.0000194706.61224.29","volume":"28","author":"Kim","year":"2005","unstructured":"Kim SW, Shin IS, Kim JM et al. (2005) Bupropion may improve restless legs syndrome: a report of three cases. Clin Neuropharmacol 28: 298\u2013301","journal-title":"Clin Neuropharmacol"},{"key":"2575_CR39","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00004714-199910000-00017","volume":"19","author":"Kraus","year":"1999","unstructured":"Kraus T, Schuld A, Pollmacher T (1999) Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol 19: 478\u2013479","journal-title":"J Clin Psychopharmacol"},{"key":"2575_CR40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.0954-6820.1985.tb08851.x","volume":"218","author":"Larsen","year":"1985","unstructured":"Larsen S, Telstad W, Sorensen O (1985) Carbamazepine therapy in restless legs. Discrimination between responders and non-responders. Acta Med Scand 218: 223\u2013227","journal-title":"Acta Med Scand"},{"key":"2575_CR41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4088\/JCP.v60n0407","volume":"60","author":"Lauerma","year":"1999","unstructured":"Lauerma H, Markkula J(1999) Treatment of restless legs syndrome with tramadol: an open study. J Clin Psychiatry 60: 241\u2013244","journal-title":"J Clin Psychiatry"},{"key":"2575_CR42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF01037942","volume":"25","author":"Lundvall","year":"1983","unstructured":"Lundvall O, Abom PE, Holm R (1983) Carbamazepine in restless legs. A controlled pilot study. Eur J Clin Pharmacol 25: 323\u2013324","journal-title":"Eur J Clin Pharmacol"},{"key":"2575_CR43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00004850-199701000-00008","volume":"12","author":"Markkula","year":"1997","unstructured":"Markkula J, Lauerma H (1997) Mianserin and restless legs. Int Clin Psychopharmacol 12: 53\u201358","journal-title":"Int Clin Psychopharmacol"},{"key":"2575_CR44","first-page":"1022","volume":"27","author":"McLean","year":"2004","unstructured":"McLean AJ (2004) The use of the dopamine-receptor partial agonist aripiprazole in the treatment of restless legs syndrome. Sleep 27: 1022","journal-title":"Sleep"},{"key":"2575_CR45","unstructured":"Medicine A.A.o.S. (2005) International classification of sleep disorders, second edn: Diagnostic and coding manual edn. American Academy of Sleep Medicine"},{"key":"2575_CR46","unstructured":"Medicine A.A.o.S. (2001) International classification of slep disorders, revised: diagnostic and coding manual. American Academy of Sleep Medicine"},{"key":"2575_CR47","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/sleep\/19.3.224","volume":"19","author":"Mellick","year":"1996","unstructured":"Mellick GA, Mellick LB (1996) Management of restless legs syndrome with gabapentin (Neurontin). Sleep 19: 224\u2013226","journal-title":"Sleep"},{"key":"2575_CR48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1081\/JDI-120039823","volume":"26","author":"Micozkadioglu","year":"2004","unstructured":"Micozkadioglu H, Ozdemir FN, Kut A et al. (2004) Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study. Ren Fail 26: 393\u2013397","journal-title":"Ren Fail"},{"key":"2575_CR49","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/sleep\/9.3.385","volume":"9","author":"Mitler","year":"1986","unstructured":"Mitler MM, Browman CP, Menn SJ et al. (1986) Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam. Sleep 9: 385\u2013392","journal-title":"Sleep"},{"key":"2575_CR50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1017\/S0317167100035794","volume":"13","author":"Moldofsky","year":"1986","unstructured":"Moldofsky H, Tullis C, Quance G, Lue FA (1986) Nitrazepam for periodic movements in sleep (sleep-related myoclonus). Can J Neurol Sci 13: 52\u201354","journal-title":"Can J Neurol Sci"},{"key":"2575_CR51","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4088\/JCP.v61n1108","volume":"61","author":"Nofzinger","year":"2000","unstructured":"Nofzinger EA, Fasiczka A, Berman S, Thase ME (2000) Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. J Clin Psychiatry 61: 858\u2013862","journal-title":"J Clin Psychiatry"},{"key":"2575_CR52","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1212\/WNL.35.3.408","volume":"35","author":"Ohanna","year":"1985","unstructured":"Ohanna N, Peled R, Rubin AH et al. (1985) Periodic leg movements in sleep: effect of clonazepam treatment. Neurology 35: 408\u2013411","journal-title":"Neurology"},{"key":"2575_CR53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.genhosppsych.2006.02.009","volume":"28","author":"Ozturk","year":"2006","unstructured":"Ozturk O, Eraslan D, Kumral E (2006) Oxcarbazepine treatment for paroxetine-induced restless leg syndrome. Gen Hosp Psychiatry 28: 264\u2013265","journal-title":"Gen Hosp Psychiatry"},{"key":"2575_CR54","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1440-1819.2004.01319.x","volume":"58","author":"Pae","year":"2004","unstructured":"Pae CU, Kim TS, Kim JJ et al. (2004) Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome? Psychiatry Clin Neurosci 58: 669\u2013670","journal-title":"Psychiatry Clin Neurosci"},{"key":"2575_CR55","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1592\/phco.28.2.271","volume":"28","author":"Page","year":"2008","unstructured":"Page RL 2nd, Ruscin JM, Bainbridge JL, Brieke AA (2008) Restless legs syndrome induced by escitalopram: case report and review of the literature. Pharmacotherapy 28: 271\u2013280","journal-title":"Pharmacotherapy"},{"key":"2575_CR56","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1192\/bjp.155.3.415","volume":"155","author":"Paik","year":"1989","unstructured":"Paik IH, Lee C, Choi BM et al. (1989) Mianserin-induced restless legs syndrome. Br J Psychiatry 155: 415\u2013417","journal-title":"Br J Psychiatry"},{"key":"2575_CR57","first-page":"132","volume":"32","author":"Perez","year":"2004","unstructured":"Perez Bravo A (2004) Utilidad del topiramato en el tratamiento del sindrome de piernas inquietas. Actas Esp Psiquiatr 32: 132\u2013137","journal-title":"Actas Esp Psiquiatr"},{"key":"2575_CR58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.genhosppsych.2007.01.007","volume":"29","author":"Perroud","year":"2007","unstructured":"Perroud N, Lazignac C, Baleydier B et al. (2007) Restless legs syndrome induced by citalopram: a psychiatric emergency? Gen Hosp Psychiatry 29: 72\u201374","journal-title":"Gen Hosp Psychiatry"},{"key":"2575_CR59","first-page":"891","volume":"28","author":"Picchietti","year":"2005","unstructured":"Picchietti D, Winkelman JW (2005) Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 28: 891\u2013898","journal-title":"Sleep"},{"key":"2575_CR60","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.jcp.0000186870.75042.25","volume":"25","author":"Pinninti","year":"2005","unstructured":"Pinninti NR, Mago R, Townsend J, Doghramji K (2005) Periodic restless legs syndrome associated with quetiapine use: a case report. J Clin Psychopharmacol 25: 617\u2013618","journal-title":"J Clin Psychopharmacol"},{"key":"2575_CR61","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.4088\/JCP.v67n1122d","volume":"67","author":"Prospero-Garcia","year":"2006","unstructured":"Prospero-Garcia KA, Torres-Ruiz A, Ramirez-Bermudez J et al. (2006) Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial. J Clin Psychiatry 67: 1820","journal-title":"J Clin Psychiatry"},{"key":"2575_CR62","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.283.6296.885-a","volume":"J","author":"Read","year":"1981","unstructured":"Read DJ, Feest TG, Nassim MA (1981) Clonazepam: effective treatment for restless legs syndrome in uraemia. Br Med J (Clin Res Ed) 283: 885\u2013886","journal-title":"Br Med"},{"key":"2575_CR63","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s00415-007-0243-z","volume":"254","author":"Romigi","year":"2007","unstructured":"Romigi A, Izzi F, Placidi F et al. (2007) Topiramate-induced restless legs syndrome: A report of two cases. J Neurol 254: 1120\u20131121","journal-title":"J Neurol"},{"key":"2575_CR64","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0924-977X(01)00080-3","volume":"11","author":"Saletu","year":"2001","unstructured":"Saletu M, Anderer P, Saletu-Zyhlarz G et al. (2001) Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam. Eur Neuropsychopharmacol 11: 153\u2013161","journal-title":"Eur Neuropsychopharmacol"},{"key":"2575_CR65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0278-5846(01)00262-7","volume":"26","author":"Saletu-Zyhlarz","year":"2002","unstructured":"Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P et al. (2002) Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry 26: 249\u2013260","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2575_CR66","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4088\/JCP.v58n0803","volume":"58","author":"Salin-Pascual","year":"1997","unstructured":"Salin-Pascual RJ, Galicia-Polo L, Drucker-Colin R (1997) Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers. J Clin Psychiatry 58: 348\u2013350","journal-title":"J Clin Psychiatry"},{"key":"2575_CR67","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/00207458809000489","volume":"38","author":"Sandyk","year":"1988","unstructured":"Sandyk R, Iacono RP, Bamford CR (1988) Spinal cord mechanisms in amitriptyline responsive restless legs syndrome in Parkinson\u2019s disease. Int J Neurosci 38: 121\u2013124","journal-title":"Int J Neurosci"},{"key":"2575_CR68","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1600-0447.1996.tb09896.x","volume":"94","author":"Sanz-Fuentenebro","year":"1996","unstructured":"Sanz-Fuentenebro FJ, Huidobro A, Tejadas-Rivas A (1996) Restless legs syndrome and paroxetine. Acta Psychiatr Scand 94: 482\u2013484","journal-title":"Acta Psychiatr Scand"},{"key":"2575_CR69","first-page":"214","volume":"8","author":"Scharf","year":"1986","unstructured":"Scharf MB, Brown L, Hirschowitz J (1986) Possible efficacy of alprazolam in restless leg syndrome. Hillside J Clin Psychiatry 8: 214\u2013223","journal-title":"Hillside J Clin Psychiatry"},{"key":"2575_CR70","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0002-9343(97)89493-4","volume":"100","author":"Schenck","year":"1996","unstructured":"Schenck CH, Mahowald MW (1996) Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med 100: 333\u2013337","journal-title":"Am J Med"},{"key":"2575_CR71","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-2003-39047","volume":"36","author":"Scherbaum","year":"2003","unstructured":"Scherbaum N, Stuper B, Bonnet U, Gastpar M (2003) Transient restless legs-like syndrome as a complication of opiate withdrawal. Pharmacopsychiatry 36: 70\u201372","journal-title":"Pharmacopsychiatry"},{"key":"2575_CR72","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/(SICI)1099-1166(200002)15:2<170::AID-GPS88>3.0.CO;2-H","volume":"15","author":"Staedt","year":"2000","unstructured":"Staedt J, Dewes D, Danos P, Stoppe G (2000) Can chronic neuroleptic treatment promote sleep disturbances in elderly schizophrenic patients? Int J Geriatr Psychiatry 15: 170\u2013176","journal-title":"Int J Geriatr Psychiatry"},{"key":"2575_CR73","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF01271247","volume":"103","author":"Staedt","year":"1996","unstructured":"Staedt J, Stoppe G, Riemann H et al. (1996) Lamotrigine in the treatment of nocturnal myoclonus syndrome (NMS): two case reports. J Neural Transm 103: 355\u2013361","journal-title":"J Neural Transm"},{"key":"2575_CR74","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1590\/S0004-282X2002000600027","volume":"60","author":"Teive","year":"2002","unstructured":"Teive HA, de Quadros A, Barros FC, Werneck LC (2002) Sindrome das pernas inquietas com heranca autossomica dominante piorada pelo uso de mirtazapina: relato de caso. Arq Neuropsiquiatr 60: 1025\u20131029","journal-title":"Arq Neuropsiquiatr"},{"key":"2575_CR75","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/bmj.288.6415.444","volume":"J","author":"Telstad","year":"1984","unstructured":"Telstad W, Sorensen O, Larsen S et al. (1984) Treatment of the restless legs syndrome with carbamazepine: a double blind study. Br Med J (Clin Res Ed) 288: 444\u2013446","journal-title":"Br Med"},{"key":"2575_CR76","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0006-3223(91)90185-O","volume":"30","author":"Terao","year":"1991","unstructured":"Terao T, Terao M, Yoshimura R, Abe K (1991) Restless legs syndrome induced by lithium. Biol Psychiatry 30: 1167\u20131170","journal-title":"Biol Psychiatry"},{"key":"2575_CR77","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/ajkd.2001.25202","volume":"38","author":"Thorp","year":"2001","unstructured":"Thorp ML, Morris CD, Bagby SP (2001) A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients. Am J Kidney Dis 38: 104\u2013108","journal-title":"Am J Kidney Dis"},{"key":"2575_CR78","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(05)70139-3","volume":"4","author":"Trenkwalder","year":"2005","unstructured":"Trenkwalder C, Paulus W, Walters AS (2005) The restless legs syndrome. Lancet Neurol 4: 465\u2013475","journal-title":"Lancet Neurol"},{"key":"2575_CR79","unstructured":"Trenkwalder C.e.a. (2007) Leitlinie zur Diagnose und Therapie des Restless-Legs-Syndroms (RLS), Newsletter der Deutschen Gesellschaft f\u00fcr Neurologie, http:\/\/www.dgn.org\/fileadmin\/leit05\/RLS_Sommer_2007.pdf"},{"key":"2575_CR80","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.sleep.2006.11.015","volume":"8","author":"Ulfberg","year":"2007","unstructured":"Ulfberg J, Bjorvatn B, Leissner L et al. (2007) Comorbidity in restless legs syndrome among a sample of Swedish adults. Sleep Med 8: 768\u2013772","journal-title":"Sleep Med"},{"key":"2575_CR81","first-page":"72","volume":"13","author":"Ware","year":"1984","unstructured":"Ware JC, Brown FW, Moorad PJ et al. (1984) Nocturnal myoclonus and tricyclic antidepressanats. Sleep Res 13: 72","journal-title":"Sleep Res"},{"key":"2575_CR82","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2002-31514","volume":"35","author":"Wetter","year":"2002","unstructured":"Wetter TC, Brunner J, Bronisch T (2002) Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry 35: 109\u2013111","journal-title":"Pharmacopsychiatry"},{"key":"2575_CR83","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11910-008-0033-y","volume":"8","author":"Winkelmann","year":"2008","unstructured":"Winkelmann J (2008) Genetics of restless legs syndrome. Curr Neurol Neurosci Rep 8: 211\u2013216","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2575_CR84","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1389-9457(00)00025-3","volume":"2","author":"Winkelmann","year":"2001","unstructured":"Winkelmann J, Schadrack J, Wetter TC et al. (2001) Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients. Sleep Med 2: 57\u201361","journal-title":"Sleep Med"},{"key":"2575_CR85","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.biopsych.2005.04.022","volume":"58","author":"Yang","year":"2005","unstructured":"Yang C, White DP, Winkelman JW (2005) Antidepressants and periodic leg movements of sleep. Biol Psychiatry 58: 510\u2013514","journal-title":"Biol Psychiatry"},{"key":"2575_CR86","first-page":"263","volume":"4","author":"Youssef","year":"2005","unstructured":"Youssef EA, Wagner ML, Martinez JO, Hening W (2005) Pilot trial of lamotrigine in the restless legs syndrome. Sleep Med 6: 89Zucconi M, Coccagna G, Petronelli R et al. (1989) Nocturnal myoclonus in restless legs syndrome effect of carbamazepine treatment. Funct Neurol 4: 263\u2013271","journal-title":"Funct Neurol"},{"key":"2575_CR87","first-page":"263","volume":"4","author":"Zucconi","year":"1989","unstructured":"Zucconi M, Coccagna G, Petronelli R et al. (1989) Nocturnal myoclonus in restless legs syndrome effect of carbamazepine treatment. Funct Neurol 4: 263\u2013271","journal-title":"Funct Neurol"},{"key":"2575_CR88","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4088\/JCP.v66n0805","volume":"66","author":"Cohrs","year":"2005","unstructured":"Cohrs S, Meier A, Neumann AC et al. (2005) Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy malesubjects. J Clin Psychiatry 66: 989\u201396","journal-title":"J Clin Psychiatry"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-008-2575-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-008-2575-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-008-2575-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:40:54Z","timestamp":1684608054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-008-2575-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,30]]},"references-count":88,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["2575"],"URL":"https:\/\/doi.org\/10.1007\/s00115-008-2575-2","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,30]]}}}